Search Within

Computational Oncology Service

Formats
  1. Journal Article (592)
  2. Meeting Abstract (384)
  3. Editorial (21)
  4. Review (17)
  5. Conference Paper (7)
  6. Research Letter (7)
  7. Guidelines (3)
  8. Book Section (2)
  9. Miscellaneous (1)
Groups
  1. Epidemiology and Biostatistics (1034)
  2. GSK Faculty (979)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  4. Human Oncology and Pathogenesis Program (653)
  5. Department of Medicine (587)
  6. Sloan Kettering Institute Postdocs (581)

More Groups

People
  1. Nikolaus Schultz (491)
  2. Elli Papaemmanuil (213)
  3. Michael Berger (179)
  4. David Solit (165)
  5. Francisco Sanchez Vega (138)
  6. Jianjiong Gao (132)

More People

Years
  1. 2025 (62)
  2. 2024 (94)
  3. 2023 (102)
  4. 2022 (144)
  5. 2021 (86)
  6. 2020 (115)

More Years

Publications
  1. Journal of Clinical Oncology (122)
  2. Blood (101)
  3. Cancer Research (84)
  4. Clinical Cancer Research (52)
  5. Nature Communications (41)
  6. Nature (36)

More Publications

Publishers
  1. American Association for Cancer Research (182)
  2. Nature Publishing Group (150)
  3. American Society of Clinical Oncology (142)
  4. American Society of Hematology (115)
  5. Cell Press (70)
  6. Oxford University Press (55)

More Publishers

Results (1034)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clonal evolution in metastatic rhabdomyosarcoma
    Meeting Abstract

    Kinnaman, M.; Makohon-Moore, A.; Bouvier, N.; Glodzik, D.; Levine, M.; Papaemmanuil, E.; Dela Cruz, F.; Wexler, L.; Kung, A.; Iacobuzio-Donahue, C.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas
    Meeting Abstract

    Shoushtari, A. N.; Sanchez-Vega, F.; Kantheti, H.; Callahan, M. K.; Postow, M. A.; Barker, C. A.; Chatila, W. K.; Jonsson, P.; Ariyan, C. E.; Brady, M. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CTC versus biopsy tissue sequencing: A concordance analysis of genomic copy number profile from mCRPC patients (pts)
    Meeting Abstract

    Scher, H. I.; Lee, J.; Dago, A. E.; Barnett, E.; Sutton, R.; Carbone, E.; Schreiber, N. A.; Hullings, M.; Ebrahim, N.; Landers, M. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
    Meeting Abstract

    Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save